RARE DISEASES OF THE BLOOD SYSTEM: A CLINICAL CASE OF VIRUS-ASSOCIATED BONE MARROW APLASIA IN A PATIENT WITH A HEREDITARY MEMBRANOPATHY (REVIEW)

Author: Zabela A.V.¹, Selivanov V.S.², Babaeva T.N.³, Kovynev I.B.⁴

Abstract

The aim of study was to research and present literature data regarding the investigations of some combined types of anemia in pregnancy and to describe the clinical case of pregnancy associated with primary parvovirus B19 infection and newly diagnosed hereditary erythrocyte membrane disorder. The contemporary information about the etiology, the prevalence, structure and some features of pathogenesis of parvovirus infection based on literature data was given. The huge prevalence of this infection (according to data of different sources the serum level of parvovirus B19 specific antibodies may be detect in 90 % of population), its threat for fetus and risk of severe complications in patients with immunodeficiency, as well as possibility of development of total depression of hematopoiesis in patients with hereditary erythrocyte membrane disorders, such as Minkowsky-Chauffard disease, determine the relevance and significance of the discussed topic. Furthermore, this clinical case, which illustrates the features of primary parvovirus B19 infection in patient with hereditary hemolytic anemia and the difficulties of differential diagnosis, demonstrates the importance of parvovirus infection markers detection, which is not available in the most TORCH-panel.

Key words

parvovirus B19, HPV-B19, anemia among pregnant women, hereditary hemolytic anemia, aplastic crisis

References

Anan'eva L.P. Infections, caused by parvovirus B19. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2002. (4). 32-35. [In Russian].

Blümel J, Schmidt I, Effenberger W, Seitz H., Willkommen H., Brackmann H.H., Löwer J., Eis-Hübinger A.M. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion. 2002. 42. 1473-1481.

Brown K.E., Mori J., Cohen B.J., Field A.M. In vitro propagation of parvovirus B19 in primary fetal liver culture. J. Gen. Virol. 1991. 72. 741-745.

Brown T., Anand A., Ritchie L.D., Clewley J.P., Reid T.M.S. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984. 2. 1033–1034.

Corcoran A., Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J. Med. Microbiol. 2004. 53. 459–475.

Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat. Diagn. 2004. 24. 513-518.

Gratacós E., Torres P.J., Vidal J., Antolín E., Costa J., Jiménez de Anta M.T., Cararach V., Alonso P.L., Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 1995. 171. 1360–1363.

Heegaard E.D., Brown K.E. Human parvovirus B19. Clin. Microbiol. Rev. 2002. 15. (3). 485-505.

Hübschen M., Mihneva Z., Mentis A.F, Schneider F., Aboudy Y., Grossman Z., Rudich H., Kasymbekova K., Sarv I., Nedeljkovic J., Tahita M.C., Tarnagda Z., Ouedraogo J.B., Gerasimova A.G., Moskaleva T.N., Tikhonova N.T., Chitadze N., Forbi J.C., Faneye A.O., Otegbayo J.A., Charpentier E., Muller C.P. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype and suggests the spread of genotype 3b. J. Clin. Microbiol. 2009. 47. (11). 3735–3738.

Koch W.C., Harger J.H., Barnstein B., Adler S.P. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr. Infect. Dis J. 1998. 17. 489-494.

Lavrentyeva I.N., Antipova A.Y. Human parvovirus B19: virus characteristics, distribution and diagnostics of parvovirus infection. Infektsiya i immunitet = Russian Journal of Infection and Immunity. 2013. 3. (4). 311-322. [In Russian].

Lefrère J.J., Couroucé A.M., Bertrand Y., Girot R., Soulier J.P. Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations. Am. J. Hematol. 1986. 23. (3). 271-275.

Luo Y., Qiu J. Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol. 2015. 10. (2). 155-167.

Miyagawa E., Yoshida T., Takahashi H., Yamaguchi K., Nagano T., Kiriyama Y., Okochi K., Sato H. Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J. Virol. Methods. 1999. 83. 45-54.

Nagel H.T., De Haan T.R., Vandenbussche F.P., Oepkes D., Walther F.J. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet. Gynecol. 2007. 109. 42-47.

Nikishov O.N., Kuzin A.A., Antipova A.Yu. Parvovirus infection – contemporary issues in epidemiology and clinical medicine. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and vaccinal prevention. 2015. 83. (4). 31- 32. [In Russian].

Norbeck O., Papadogiannakis N., Petersson K., Hirbod T., Broliden K., Tolfvenstam T. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin. Infect. Dis. 2002. 35. 1032-1038.

Ozawa K., Kurtzman G., Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science. 1986. 233. 883-886.

Pashinyan A.G., Runikhina N.K., Mokeeva E.Yu. Erythema infectiosum: clinical case. Rossiiskiy zhurnal kozhnykh i venericheskikh bolezney = Russian Journal of Skin and Venereal Diseases. 2016. 19. (4). 206-209. [In Russian].

Public Health Laboratory Service Working Party on Fifth Disease Prospective study of human parvovirus infection in pregnancy. BMJ. 1990. 300. 1166–1170.

Segata M., Chaoui R., Khalek N., Bahado-Singh R., Paidas M.J., Mari G. Fetal thrombocytopenia secondary to parvovirus infection. Am. J. Obstet. Gynecol. 2007. 196. 61-64.

Sosa C.E., Mahony J.B., Luinstra K.E., Sternbach M., Chernesky M.A. Replication and cytopathology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells. J. Med. Virol. 1992. 36. 125-130.

Takahashi T., Ozawa K., Takahashi K., Okuno Y., Muto Y., Takaku F., Asano S. DNA replication of parvovirus B 19 in a human erythroid leukemia cell line (JK-1) in vitro. Arch. Virol. 1993. 131. 201-208.

Virology: principles and applications. Eds J. Carter, V. Saunders. Chichester: John Wiley & Sons Ltd., 2007. 137–146.

Weigel-Kelley K.A., Yoder M.C., Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic. J. Virol. 2001. 75. (9). 4110–4116.

Wong A., Tan K.H., Tee C.S., Yeo G.S.H. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med. J. 2000. 1. (4). 151–155.

Zavattoni M., Paolucci S., Sarasini A., Tassis B., Rustico M., Quarenghi A., Piralla A., Baldanti F. Diagnostic and prognostic value of molecular and serological investigation of human parvovirus B19 infection during pregnancy. New Microbiol. 2016. 39. (3). 181-185.

Zerbini M., Gentilomi G.A., Gallinella G., Morandi R., Calvi S., Guerra B., Musiani M. Intra-uterine parvovirus B19 infection and meconium peritonitis. Prenat. Diagn. 1998. 18. 599-606.

About Authors (Correspondence):

Zabela A.V. – student of the 5th course of the pediatric faculty, e-mail: Zabela2018@inbox.ru

Full Text

snmzh_1-2019_zabela_84-89.pdf

Received: 27/02/2019

Accepted: 27/02/2019